PROVEN offers state-of-the-art technology. With an infrastructure designed around the experience of our leadership, including experts who designed and built systems for the PROVEN United States Department of Defense. In addition, our partnership with CERTIFY Health, the leading provider of patient engagement and authentication globally, allows us to come to the table with a lot of highly trained professionals who specialize in encryption and secured data.

Our technology team is packed with cryptographers, artificial intelligent experts, hardware designers and solutions engineers who have previously maintained the entire Department of Defense IT infrastructure. In fact, eight of our expert team members carry the highest-level DOD security clearances.

Our team also has a successful background in worldwide deployments. They skillfully handle IT security through their experience with the United States government. (Of course, for the rest of us at PROVEN, their intense tactical training makes company-sponsored paintball activities more like Seal training than a week-day off-site team-building game!) As technology improves so will our tech stack. PROVEN is constantly upgrading equipment, training and security measures. Our commitment is to excellence.


Peter Gallic


Peter serves as the Chief Executive Officer for PROVEN. Prior to that he was President of Sociallity Group where he incubated several successful healthcare ventures, focusing on virtual medical solutions. He started his career in finance working in the CMBS segment with a focus on hospitality lending, leading him to a three-year stint with the Chinese Tourism Authority where he helped build vacation programs and promote travel. Peter also worked at Absolute Life Solutions where he designed an effective tool for analyzing mortality risk. The tool was used to reprice risk on hundreds of millions of longevity assets, saving the company untold millions. He is a behavioral economist and alumni of Ateneo De Manila where he received an Economics degree.

Rachel Scharfman


Accomplished leader with expertise building and executing effective global strategies that increase revenue, customer engagement, and competitive differentiation for global organizations, directing large teams and managing multimillion-dollar budgets. As the Chief Operating Officer and Vice President of Marketing at PROVEN, she works on healthcare programs for state governments, COVID-19, telehealth, and behavioral health programs. Before PROVEN she served as the Vice President of Marketing & Sales at BioDerm, where she led the strategy and execution for all facets of sales and marketing, as well as managing their Durable Medical Equipment business, and the company’s 5-year partnership with Medline, expanding distribution from 30 to 1100 representatives. Prior to BioDerm, she was the acting Chief Marketing Officer for DenTek Oral Care, where she developed a top-performing marketing team, a three-year innovation roadmap with a robust stage-gate process to drive upstream and downstream growth, and positioned the private equity owned company for acquisition at 12X EBITDA. She has a demonstrated record of success establishing strong relationships, growing business, and boosting revenue in a series of additional roles with Almar Sales, The Pokémon Company, and other global corporations. Mrs. Scharfman holds a Master of Business Administration from the University of Florida, BS in Business Management, and a BA in Theater from Florida State University

JP Robinson


At MCA Records, he began as a young production designer and worked his way up to Senior Art Director. Later at Geffen Records, JP quickly became the Creative Director of the record label by displaying excellence in imagery and through a work ethic that attracted the attention of the musicians and executives of the parent company, Universal Music Group. Within 10 years at UMG, JP became a senior vice president, moving on to become the creative director for Island Def Jam Music Group’s list of culturally relevant artists. Then, in 2011, JP moved to Sony Music’s Epic Records to start their creative department. At both major companies, he collaborated with the highest executives of the label to craft and execute the plan he envisioned. His next step was to create Composite, his own independent art company in which he remains, working with superstar musicians including Rihanna, Ciara, DJ D-Nice and Tim McGraw & Faith Hill. JP continues to pair creative solutions with music and entertainment by connecting relevant culture and the commercial needs of companies like Viacom, Seagrams, Jeep and Unilever.

Dan Gallic

(CTO )

With more than 30 years of expertise in programming, engineering, and applied materials, he is an expert at leading fast-paced product development SaaS teams to a successful launch with mass production in mind. He is credited with creating the first encrypted communications platform on cots devices to be used in open networks and currently holds a coveted United States Department of Defense clearance. Mr. Gallic is a valued expert in managed security over computer platforms. In addition to his vast engineering experience, he chairs the Technology Board for Visit Mexico where he is responsible for leading technical advances and offerings to nearly 400,000 Mexican businesses dependent on tourism. In this capacity, he creates “best-in-breed technological services” which customizes the approach, to small- and medium-sized Mexican businesses, allowing them to streamline and improve positive experiences for travelers visiting Mexico.

C. Buddy Creech, MD, MPH

(Director, Vanderbilt Vaccine Research Program)

C. Buddy Creech, MD, MPH, FPIDS is Associate Professor of Pediatrics, Division of Pediatric Infectious Diseases, at the Vanderbilt University School of Medicine in Nashville, Tennessee. He serves as Director of the Vanderbilt Vaccine Research Program, Principal Investigator of the NIH-funded Vanderbilt Vaccine and Treatment Evaluation Unit, and Co-Principal Investigator of the CDC-sponsored Clinical Immunization Safety Assessment Network. Dr. Creech’s research interests focus on the development and evaluation of new vaccines and therapeutics, particularly vaccines targeting influenza, pertussis, and S. aureus. His work combines innovative clinical trial design and next-generation immunologic assays to characterize the human response to infection and disease. He is currently leading COVID-related clinical trials at VUMC, including the evaluation of novel treatment options for hospitalized patients with COVID and trials of candidate SARS-CoV-2 vaccines. Dr. Creech received a Bachelor of Science degree in Biology, cum laude, from Vanderbilt University prior to graduating with high honors from the University of Tennessee College of Medicine in Memphis, TN. He received a master’s degree in public health during his fellowship in pediatric infectious diseases at Vanderbilt

Translate »